Baipharm
ChemLinkedMarketChemicalFoodCosmeticBaiPharm Agrochemical Japan
News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
INDUSTRY
Marketing Approval Priority Review and Approval Innovative Drugs Generic Drugs Drug Registration New Drugs
Monthly Report: New Drug Approvals in China | Aug. 2021 In Aug. 2021, China NMPA nodded for nine new drug products including Tislelizumab Injection, Apremilast Tablet and Nivolumab Injection.
Sep 14, 2021
INDUSTRY
Marketing Approval Drug Registration
Monthly Report: New Drug Approvals in China | July 2021 In July 2021, China NMPA granted 14 new drug approvals for ten imported products and four domestic ones.
Aug 16, 2021
INDUSTRY
Marketing Approval Priority Review and Approval Drug Registration New Drugs
Monthly Report: New Drug Approvals in China | May 2021 In May 2021, China NMPA granted approvals to a total of nine innovative new drugs, improved new drugs, imported original drugs and first generics.
Jun 15, 2021
INDUSTRY
Marketing Approval Priority Review and Approval Drug Registration New Drugs
Monthly Report: New Drug Approvals in China | April 2021 In Apr. 2021, China NMPA approved a total of 12 new drugs. Eight of them are therapeutic biological products and the other four are chemical drugs.
May 14, 2021
Most Popular